MANCIA, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 94.837
AS - Asia 54.716
EU - Europa 40.191
SA - Sud America 8.488
AF - Africa 854
Continente sconosciuto - Info sul continente non disponibili 102
OC - Oceania 99
AN - Antartide 1
Totale 199.288
Nazione #
US - Stati Uniti d'America 92.777
SG - Singapore 21.546
CN - Cina 12.919
HK - Hong Kong 10.850
RU - Federazione Russa 8.770
BR - Brasile 6.864
DE - Germania 5.765
SE - Svezia 5.550
IE - Irlanda 5.325
VN - Vietnam 4.712
IT - Italia 4.541
UA - Ucraina 3.633
GB - Regno Unito 2.202
CA - Canada 1.461
KR - Corea 1.147
FI - Finlandia 1.020
FR - Francia 851
IN - India 779
AR - Argentina 652
AT - Austria 646
TR - Turchia 432
BD - Bangladesh 396
NL - Olanda 380
MX - Messico 372
ZA - Sudafrica 331
ID - Indonesia 326
JP - Giappone 291
EC - Ecuador 281
PL - Polonia 277
IQ - Iraq 257
DK - Danimarca 199
ES - Italia 175
BE - Belgio 166
CO - Colombia 151
VE - Venezuela 135
PY - Paraguay 129
CZ - Repubblica Ceca 119
PK - Pakistan 113
UZ - Uzbekistan 101
SA - Arabia Saudita 99
PE - Perù 95
CL - Cile 92
MA - Marocco 92
AE - Emirati Arabi Uniti 91
IR - Iran 88
KE - Kenya 86
EG - Egitto 81
AU - Australia 79
EU - Europa 75
TN - Tunisia 67
GR - Grecia 63
CH - Svizzera 61
RO - Romania 60
MY - Malesia 59
PT - Portogallo 58
UY - Uruguay 57
LT - Lituania 50
IL - Israele 48
KZ - Kazakistan 46
AZ - Azerbaigian 45
TW - Taiwan 44
BG - Bulgaria 43
JO - Giordania 42
DO - Repubblica Dominicana 39
JM - Giamaica 39
DZ - Algeria 37
NP - Nepal 37
PH - Filippine 36
TT - Trinidad e Tobago 32
ET - Etiopia 29
AL - Albania 27
BO - Bolivia 24
RS - Serbia 24
NG - Nigeria 23
PA - Panama 22
TH - Thailandia 22
HU - Ungheria 20
NO - Norvegia 20
OM - Oman 20
PS - Palestinian Territory 20
SK - Slovacchia (Repubblica Slovacca) 20
SN - Senegal 20
CR - Costa Rica 19
LV - Lettonia 19
NZ - Nuova Zelanda 19
MK - Macedonia 18
AM - Armenia 17
BB - Barbados 17
HN - Honduras 17
LB - Libano 17
LK - Sri Lanka 17
BH - Bahrain 16
BY - Bielorussia 16
MU - Mauritius 16
BA - Bosnia-Erzegovina 15
GE - Georgia 14
XK - ???statistics.table.value.countryCode.XK??? 14
A2 - ???statistics.table.value.countryCode.A2??? 12
MD - Moldavia 12
AO - Angola 11
Totale 199.059
Città #
Ann Arbor 13.090
Singapore 11.760
Hong Kong 10.802
Woodbridge 8.064
Fairfield 7.994
Ashburn 6.681
Houston 5.723
Dublin 5.087
Chandler 4.641
Jacksonville 3.878
Frankfurt am Main 3.588
Wilmington 3.450
Seattle 3.125
New York 2.760
Dearborn 2.675
Cambridge 2.610
Hefei 2.427
Princeton 2.041
Santa Clara 1.939
Beijing 1.757
Dallas 1.424
Ho Chi Minh City 1.418
Milan 1.337
Los Angeles 1.281
Seoul 1.096
Lawrence 968
Nanjing 957
Altamura 954
Hanoi 930
The Dalles 894
Moscow 851
Chicago 740
Shanghai 694
Buffalo 657
São Paulo 651
San Diego 597
Lachine 581
Vienna 499
Hangzhou 494
Guangzhou 386
Dong Ket 356
Boardman 352
Andover 320
Council Bluffs 319
Nanchang 315
Munich 308
Shenyang 296
Toronto 293
Helsinki 280
Ottawa 276
Salt Lake City 275
Hebei 260
London 258
Falls Church 243
Tianjin 233
Changsha 231
Rio de Janeiro 216
Jiaxing 189
Norwalk 186
Nuremberg 186
Tokyo 186
Warsaw 181
Columbus 157
Haiphong 143
Jakarta 143
Jinan 143
San Jose 143
Brussels 140
Elk Grove Village 138
Da Nang 137
Belo Horizonte 132
Brooklyn 130
Fremont 130
Rome 130
Zhengzhou 128
Brasília 126
Phoenix 123
Johannesburg 121
Mountain View 121
Stockholm 120
Montreal 119
Philadelphia 114
Tampa 111
Kunming 107
Curitiba 106
Orem 106
San Francisco 103
Huizen 99
Atlanta 96
Denver 95
Porto Alegre 94
Lissone 93
Mexico City 93
Quito 93
Chennai 92
Turku 91
Biên Hòa 90
Guayaquil 89
Tashkent 88
Mumbai 86
Totale 131.630
Nome #
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) 814
Changes in 24 h ambulatory blood pressure and effects of angiotensin II receptor blockade during acute and prolonged high-altitude exposure: A randomized clinical trial 600
Echocardiographic Phenotypes of Subclinical Organ Damage: Clinical and Prognostic Value in the General Population. Findings from the Pamela Study 578
Predictors of pwv progression over a three years follow up: focus on psychological characteristics 438
Relationship between arterial distensibility and coronary atherosclerosis in angina patients 412
Why were the 2023 Guidelines of the European Society of Hypertension not developed as Joint Guidelines together with the European Society of Cardiology? 410
Good adherence to therapy with statins reduces the risk of adverse clinical outcomes even among very elderly. Evidence from an Italian real-life investigation 405
Effects of Renal Sympathetic Denervation on Arterial Stiffness and Blood Pressure Control in Resistant Hypertensive Patients: A Single Centre Prospective Study 401
Good adherence to therapy with statins reduces the risk of adverse clinical outcomes even among very elderly. Evidence from an Italian real-life investigation 396
Erratum: Effects of Renal Sympathetic Denervation on Arterial Stiffness and Blood Pressure Control in Resistant Hypertensive Patients: A Single Centre Prospective Study [High Blood Press Cardiovasc Prev, DOI 10.1007/s40292-015-0121-4] 395
The impact of systolic and diastolic blood pressure variability on mortality is age dependent: Data from the Dublin Outcome Study 389
Blood pressure levels and control in Italy: Comprehensive analysis of clinical data from 2000-2005 and 2005-2011 hypertension surveys 382
Heart rate as a sympathetic marker during acute adrenergic challenge 379
Good adherence to therapy with statins reduces the risk of adverse clinical outcomes even among very elderly. Evidence from an Italian real-life investigation 365
In remembrance: the life and legacy of George L. Bakris (1952-2024) 358
Does the 9p region affect arterial stiffness? Results from a cohort of hypertensive individuals 356
Sympathetic Overactivation in the Resistant Hypertensive Phenotype: A Meta-Analysis of Published Studies 355
Persistence of arterial functional abnormalities after successful coronary revascularization 355
Comparison of echotracking and magnetic resonance assessment of abdominal aorta distensibility and relationships with pulse wave velocity 353
Reproducibility of dipping/nondipping pattern in untreated essential hypertensive patients: impact of sex and age 350
Hemodynamic effects of acute and prolonged administration of nitrendipine in essential hypertension 339
Cardiopulmonary receptor modulation of plasma renin activity in normotensive and hypertensive subjects 339
Studio della distensibilita arteriosa nell'uomo. Quali i meccanismi di modulazione, come varia in condizioni patologiche ed effetto della terapia [Study of arterial distensibility in man. Modulating mechanisms, pathological conditions and effects of treatment] 335
Calcium antagonists and neural control of circulation in essential hypertension 332
Early alterations in left ventricular diastolic function in normotensive diabetic patients 327
In healthy normotensive subjects age and blood pressure better predict subclinical vascular and cardiac organ damage than atherosclerosis biomarkers 326
Early cardiac and vascular structural changes in subjects with parental hypertension 322
The effects of sex and method of blood pressure measurement on genetic associations with blood pressure in the PAMELA study 321
European society of hypertension guidelines for blood pressure monitoring at home: A summary report of the second international consensus conference on home blood pressure monitoring 319
Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate 317
Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy 312
External adjustment for unmeasured confounders improved drug-outcome association estimates based on health care utilization data 311
Determinants of carotid-femoral pulse wave velocity progression in hypertensive patients over a 3.7 years follow-up 309
Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified 306
Early 24-hour blood pressure elevation in normotensive subjects with parental hypertension 306
Effect on resting blood pressure and blood pressure homeostasis of short-term administration of the alpha 1-adrenergic receptor antagonist, trimazosin, in hypertension 305
Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues 302
Women discontinue antihypertensive drug therapy more than men. Evidence from an Italian population-based study 302
Differing associations for sport versus occupational physical activity and cardiovascular risk 302
Changes in 24 hour blood pressure and in cardiac and vascular structure in normotensive subjects with parental hypertension 300
Long-term exposure to antihypertensive drugs and the risk of cancer occurrence: evidence from a large population-based study 297
Gender-related differences in serum uric acid in treated hypertensive patients fromcentral and east European countries: Findings from the blood pressure control rate and cardiovascular risk profile study 297
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies 296
2013 ESH/ESC practice guidelines for the management of arterial hypertension 296
Cardiopulmonary receptor regulation of renin release 294
Baroreflex control of heart rate during sleep in severe obstructive sleep apnoea: effects of acute CPAP. 290
Statins and the risk of diabetes: Evidence from a large population-based cohort study 290
Radial artery wall alterations in genetic hemochromatosis before and after iron depletion therapy 289
Antihypertensive Medications, Loop Diuretics, and Risk of Hip Fracture in the Elderly: A Population-Based Cohort Study of 81,617 Italian Patients Newly Treated Between 2005 and 2009 289
Better compliance to antihypertensive medications reduces cardiovascular risk 288
Cardiopulmonary reflex before and after regression of left ventricular hypertrophy in essential hypertension 288
Home blood pressure telemonitoring improves hypertension control in general practice. the TeleBPCare study 287
Psychological Predictors of Arterial Stiffness Progression over a Three Years Follow Up 286
Blood pressure response to labetalol in twice and three times daily administration during a 24‐hour period. 282
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 282
Low anthracyclines doses-induced cardiotoxicity in acute lymphoblastic leukemia long-term female survivors 279
Acute effect of high-fat meal on endothelial function in moderately dyslipidemic subjects 278
Twenty-four-hour blood pressure profile and blood pressure variability in untreated hypertension and during antihypertensive treatment by once-a-day nadolol 277
High-altitude exposure of three weeks duration increases lung diffusing capacity in humans 277
2007 ESH-ESC guidelines for the management of arterial hypertension - The task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC) 276
Blood pressure targets in type 2 diabetes. Evidence against or in favour of an aggressive approach 276
Blood pressure and heart rate variabilities in normotensive and hypertensive human beings 275
8c.04: Possible role of arterial function in cancer treatment targeting vascular endothelial growth factor receptor oncologic response 274
Effect of angiotensin converting enzyme inhibition on cardiovascular regulation during reflex sympathetic activation in sodium-replete patients with essential hypertension 273
Evaluation of the baroreceptor-heart rate reflex by 24-hour intra-arterial blood pressure monitoring in humans 272
Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population 271
Heterogeneity in antihypertensive treatment discontinuation between drugs belonging to the same class 271
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 270
Similarities and differences between renal sympathetic denervation and carotid baroreceptor stimulation 270
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. 270
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 269
The Pamela study: main findings and perspectives 267
Effects of celiprolol on reflex control of the cardiovascular system in essential hypertension 267
Incidence of cardiovascular events in Italian patients with early discontinuations of antihypertensive, lipid-lowering, and antidiabetic treatments 266
Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: Data from the Pressioni Arteriose Monitorate e Loro Associazioni study 266
Different effects of antihypertensive treatment on office and ambulatory blood pressure: Ameta-analysis 266
Cardiovascular risk factor profile in an italian cohort of patients with rheumatoid arthritis: results of a three years follow-up 266
Twenty-four-hour hemodynamic profile during treatment of essential hypertension by once-a-day nadolol 264
Influence of cardiopulmonary receptors on the bradycardiac responses to carotid baroreceptor stimulation in man 264
2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension 263
Effects of selective and nonselective beta-blockade on 24-h ambulatory blood pressure under hypobaric hypoxia at altitude 263
Regional differences in sympathetic activation in lean and obese normotensive individuals with obstructive sleep apnoea 262
Left atrial volume in elite athletes: A meta-analysis of echocardiographic studies 262
Increased arterial stiffness in normoglycemic normotensive offspring of type 2 diabetic parents 261
Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study 261
Fluctuations of radial artery distensibility throughout the menstrual cycle 261
Brachial and central blood pressure in HIV-infected subjects 261
Early impairment of large artery structure and function in Type I diabetes mellitus 260
Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis 259
Reduced discontinuation of antihypertensive treatment by two-drug combination as first step. Evidence from daily life practice 258
Modification of arterial baroreflexes by captopril in essential hypertension 258
Management of antihypertensive drugs in three European countries 257
Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites 257
Effects of ageing on the cardiopulmonary receptor reflex in normotensive humans 257
Balancing cardiovascular benefit and diabetogenic harm of therapy with statins: Real-world evidence from Italy 257
Clinical value of NT-proBNP assay in the emergency department for the diagnosis of heart failure (HF) in very elderly people 255
Control of blood pressure by carotid sinus baroreceptors in human beings 255
Heart Function and Myocardial Tissue Characterization in Patients with HCV Related Cirrhosis: Diastolic Dysfunction and Cardiac Hypertrophy 254
Habitual coffee consumption and risk of cardiovascular and all-cause mortality in the PAMELA hypertensive population 254
Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study 253
Totale 31.106
Categoria #
all - tutte 736.264
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 736.264


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219.544 0 0 0 0 0 1.240 1.621 1.319 1.296 1.758 805 1.505
2021/202213.869 817 1.329 1.895 1.173 969 907 796 768 760 895 1.332 2.228
2022/202318.876 2.547 5.583 1.588 1.721 1.177 2.914 156 963 1.255 129 515 328
2023/202416.456 596 752 572 586 2.676 3.829 3.078 471 1.823 305 239 1.529
2024/202539.495 2.446 5.074 1.486 1.677 3.519 934 2.225 1.447 4.222 4.926 3.998 7.541
2025/202646.926 8.851 6.956 7.057 9.388 9.729 4.945 0 0 0 0 0 0
Totale 203.692